55
Participants
Start Date
October 19, 2021
Primary Completion Date
March 31, 2024
Study Completion Date
October 31, 2024
DynamX Drug-Eluting Coronary Bioadaptor System
DynamX Drug-Eluting Coronary Bioadaptor System Implantation in Coronary Artery Lesion
Humanitas Research Hospital, Rozzano
Lead Sponsor
Istituto Clinico Humanitas
OTHER
Elixir Medical Corporation
INDUSTRY